SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is surging after reporting its first-ever quarterly net profit and strong delivery guidance, igniting bullish sentiment around its unique battery swap ecosystem and in-house AI chip development, though some anticipate continued volatility amid strong market competition.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is surging after delivering robust earnings driven by exceptional cloud infrastructure growth and a record-breaking backlog, directly addressing investor concerns about its AI-driven capital expenditures and prompting bullish sentiment for a market turnaround. The community is actively discussing the company's strong guidance and its pivot to a core AI infrastructure provider, with many celebrating the dispelling of bearish narratives.

Tria is a self-custodial neobank and cross-chain payments infrastructure designed to make onchain money usable in everyday life. It combines card spending, trading, and earning in a single account experience, so users can move value across chains without manually bridging assets, switching networks, or managing chain-specific steps. Under the hood, Tria routes every action through BestPath, an ultra-fast routing and execution layer that takes an intent like “spend,” “swap,” “send,” or “earn” and completes it end-to-end on the optimal path. Tria operates in two modes: a consumer app that includes a Visa-powered card, spot swaps, perpetual futures, and Earn vaults, and a developer and institutional layer that integrates with protocols and ecosystems to embed Tria’s execution rails wherever value already moves. The end goal is simple: one continuous flow for money across chains, with self-custody by default and a product experience that feels effortless for normal users worldwide.

TRIA

Community buzz around TRIA CRYPTO is surging, fueled by expectations of a major national online bank partnership and new exchange listings. Discussions highlight its potential as a prominent banking project in the crypto space, with many anticipating further upward momentum.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is trending as investors anticipate its upcoming 10-K filing to confirm a strong turnaround, with preliminary Q4 results already showcasing significant net income and debt reduction. The community is actively discussing its "deep value" and short squeeze potential, noting the company's market capitalization is reportedly below the value of its major holdings like Babcock & Wilcox.

Polaryx Therapeutics, Inc. engages in the manufacturing of biotechnology products. Its pipeline of products includes PLX-100, PLX-200, and PLX-300. The company was founded by Hahn-Jun Lee on August 22, 2014 and is headquartered in Paramus, NJ.

Polaryx Therapeutics Inc.

Polaryx Therapeutics is trending after announcing a key development for its SOTERIA Phase 2 trial, sparking a significant surge in retail trading volume and price. As a volatile, recently direct-listed clinical-stage biotech, the community is actively discussing its potential for a short squeeze and further notable price movements.

XAU-9999 is an Ethereum-based meme token that satirizes gold-backed digital assets by offering a symbolic, valueless version of “digital gold” with no physical backing or real-world utility. It is created solely for entertainment, community participation, and cultural parody, reflecting internet-native humor and crypto’s obsession with wealth, status, and digital ownership. The token has no financial utility and exists purely as a social and cultural artifact.

XAU9999

XAU is trending as geopolitical tensions continue to fuel significant safe-haven demand, with community discussions centering on gold's resilience against broader economic uncertainty and shifting Federal Reserve rate expectations.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is trending due to key market access wins for its fibromyalgia drug, Tonmya, with UnitedHealthcare and Kaiser expanding coverage, alongside the company's uplisting to Nasdaq Global Select, driving bullish community discussion on accelerating sales and short squeeze potential despite historical dilution concerns.

IBEX Ltd. is a business process outsourcing company, which engages in technology-enabled customer lifecycle experience solutions. It also specializes in digital marketing, lead generation, online sales, optimization, lead conversion, customer service, billing support, technical support, multi-lingual, omni-channel, retention, renewals, up and cross sell, and win-backs. The company was founded in 1984 and is headquartered in Washington, DC.

IBEX Ltd

IBEX is trending following robust earnings and an uplifted fiscal year outlook, with the community actively discussing its strong fundamentals, undervaluation, and strategic AI advancements, alongside numerous technical buying opportunities.

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquisition, development, and commercialization of drug candidates for medical dermatology and respiratory diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.

Edesa Biotech Inc

Edesa Biotech is trending due to compelling positive Phase 3 data for its ARDS treatment showing significant mortality reduction, attracting notable institutional investment from firms like Point72. Community sentiment points to potential buyout interest and a significant short squeeze, fueled by continuous insider buying and the stock's increased eligibility for broader institutional funds.

Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corp. - Ordinary Shares (Paired Stock)

Carnival Corp

Carnival (CCL) is a focal point of investor debate, with discussions fueled by Middle East geopolitical tensions driving oil price volatility and impacting travel sector sentiment. The community is actively discussing whether the stock is "ridiculously oversold" given its record bookings and upcoming earnings with a reinstated dividend, leading to widespread "buy the dip" strategies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bank of Montreal Can Has $208.74 Million Holdings in Boston Scientific Corporation $BSX

Bank of Montreal Can grew its position in shares of Boston Scientific Corporation (NYSE:BSX - Free Report) by 1.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with...

BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealing Unsustainable U.S. Electrophysiology Segment Growth Rate: Levi & Korsinsky

Levi & Korsinsky, LLP alerts investors in Boston Scientific Corporation (NYSE: BSX) of a pending securities class action. Class Period: July 23, 2025 through February 3, 2026. Check if you can...

Law Offices of Frank R. Cruz Encourages Boston Scientific Corporation (BSX) Shareholders To Inquire About Securities Fraud Class Action

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Boston Scientific Corporation. (Boston Scientific...

Class Action Filed Against Boston Scientific Corporation (BSX) - May 4, 2026 Deadline to Join - Contact The Gross Law Firm

Class Action Filed Against Boston Scientific Corporation (BSX) - May 4, 2026 Deadline to Join - Contact The Gross Law Firm Class Action Filed Against Boston Scientific Corporation (BSX) - May 4, 2026...

Richard Bernstein Advisors LLC Sells 51,186 Shares of Boston Scientific Corporation $BSX

Richard Bernstein Advisors LLC cut its position in shares of Boston Scientific Corporation (NYSE:BSX - Free Report) by 54.5% in the 3rd quarter, according to the company in its most recent Form 13F...

Legal & General Group Plc Buys 463,889 Shares of Boston Scientific Corporation $BSX

Legal & General Group Plc increased its stake in Boston Scientific Corporation (NYSE:BSX - Free Report) by 4.6% in the 3rd quarter, according to the company in its most recent filing with the SEC...

Boston Scientific (NYSE:BSX) Reaches New 1-Year Low - Here's Why

Boston Scientific (NYSE:BSX) Reaches New 12-Month Low - Here's What Happened...

Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm, Encourages Boston Scientific Corporation (BSX) Shareholders to Inquire About Securities Fraud Class Action

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or...

Swiss National Bank Has $416.36 Million Stock Holdings in Boston Scientific Corporation $BSX

Swiss National Bank lowered its stake in Boston Scientific Corporation (NYSE:BSX - Free Report) by 4.7% during the third quarter, according to the company in its most recent Form 13F filing with the...

Boston Scientific Corporation $BSX Shares Acquired by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. boosted its holdings in Boston Scientific Corporation (NYSE:BSX - Free Report) by 17.4% in the third quarter, according to its most recent Form 13F filing with the SEC...

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

BSX
Boston Scientific Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BSX News

BSXBoston Scientific Corp.